North Carolina may lose pharma project after passing law targeting LGBT community

Two weeks ago North Carolina governor Gov. Pat McCrory was pointing to a proposed project by New Jersey-based Braeburn Pharmaceuticals and bragging about what a great job the state has done attracting pharma companies. But Braeburn is having second thoughts about the state after the governor last week signed a bill that eliminated local protections for gay and transgender people and limits the bathroom choices they have. In a statement to WNCN in Durham, NC, Braeburn called the law "unjust. It is slated to receive up to $275,000 in incentives for the project. "Braeburn Pharmaceuticals believes in fair treatment and equality for all individuals in their communities. We oppose any legislation that discriminates against the LGBT community," the company said. More from FiercePharmaManufacturing

Suggested Articles

Late-stage ovarian cancer patients have few options, but now the FDA is reviewing GSK's Zejula for the patient group.

The FDA has raised questions about the manufacturing of Glenmark's new molecular entity Ryaltris, a nasal spray for seasonal allergic rhinitis.

Despite unconventional support from President Donald Trump, Johnson & Johnson’s Spravato didn’t win broad backing at the VA.